Cullen/Frost Bankers’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.5K Buy
146
+131
+873% +$34.8K ﹤0.01% 798
2026
Q1
$1.64K Sell
15
-402
-96% -$57.3K ﹤0.01% 1267
2025
Q4
$69.4K Buy
417
+2
+0.5% +$335 ﹤0.01% 745
2025
Q3
$81.3K Buy
415
+390
+1,560% +$64.1K ﹤0.01% 674
2025
Q2
$2.26K Buy
25
+3
+14% +$237 ﹤0.01% 1166
2025
Q1
$1.31K Buy
22
+11
+100% +$1.02K ﹤0.01% 1204
2024
Q4
$1.46K Buy
11
+8
+267% +$751 ﹤0.01% 1195
2024
Q3
$157 Hold
3
﹤0.01% 1200
2024
Q2
$182 Buy
+3
New +$208 ﹤0.01% 1228

Other funds holding ALAB

Cullen/Frost Bankers's ALAB Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Astera Labs (ALAB) stake by 873% in Q2 2026, buying an estimated $34.8K and bringing the position to 146 shares worth $70.5K. The position accounts for ﹤0.01% of the portfolio, ranked #798.

Cullen/Frost Bankers first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. The position peaked at $81.3K in Q3 2025. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Cullen/Frost Bankers held 146 shares of Astera Labs worth $70.5K as of Q2 2026.
  • Cullen/Frost Bankers bought 131 Astera Labs shares in Q2 2026, an estimated $34.8K.
  • Astera Labs made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #798 holding.
  • Cullen/Frost Bankers first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • Cullen/Frost Bankers's Astera Labs position peaked at $81.3K in Q3 2025.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.